Chief Executive Officer
About Aurobindo Aurobindo Pharma Limited ( www.aurobindo.com ), headquartered at Hyderabad, India, manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's manufacturing facilities are approved by several leading regulatory agencies like US FDA, UK MHRA, WHO, Health Canada, MCC South Africa, ANVISA Brazil. The company's robust product portfolio is spread over 6 major therapeutic/product areas encompassing Antibiotics, Anti-Retrovirals, CVS, CNS, Gastroenterologicals, and Anti-Allergics, supported by an outstanding R&D set-up. The Company is marketing these products globally, in over 125 countries. Aurobindo Europe represents a significant segment within the Group's global presence. Aurobindo is committed to grow its operations in Europe considering the importance of the generic market. Since launching its European commercial operations in 2006 with the acquisition of Milpharm in the UK and Pharmacin in the Netherlands in 2007, Aurobindo has further expanded its footprint in continental Europe by commencing operations in several territories including (but not limited to) Italy, Spain, Portugal, Romania, Malta and Germany. Aurobindo's state of the art EU release lab and captive warehouse in Malta serves as a logistics centre for its European operations.
I hold a BSc degree, a Masters and Doctorate degree in Business Leadership as well as a coaching qualification from Henley Business School. I was in the medical industry for 14 years, occupying roles in the sales and market arenas. These days, my passion lies in the food and beverages industry. Currently being the CEO of a South African manufacturing company allows me to have insight into production, economics, sales, marketing, manufacturing and distribution. My practical approach to success is to build sustainable leadership by focusing on guiding leaders and their teams to personal growth and achievement of goals. I like to win and to work with winners!